Discovery of Immune Defense Mechanism Could Help Improve Treatments
Scientists have made a fundamental discovery about how our body's immune system clears harmful infections.
Researchers have identified a previously unknown mechanism by which the responses of key cells of the immune system are regulated.
The finding could inform research into improved treatments for allergies or chronic inflammatory diseases, such as lung and liver fibrosis, researchers say.
Scientists at the University of Edinburgh made the discovery by studying how the immune system in mice fights off parasitic worms. These parasites provoke a strong immune response, enabling researchers to carry out in-depth studies of the defence mechanisms involved.
They found that chemical signals from infecting organisms activate cells - called Th2 cells - causing them to multiply and express a key protein, known as EGFR.
The cells then migrate from the lymph nodes - where they are stored - to the site of infection, where they release defence proteins to expel the parasites.
Researchers found that Th2 cells release defence molecules when they detect the damage caused by invading parasites, but can only perform this task if they express EGFR.
This safety mechanism - unknown until now - blocks the release of defence molecules in the absence of parasites, and thereby prevents tissue damage, the team says.
The study, published in the journal Immunity, was funded by the Medical Research Council, European Union and Austrian Science Fund. It was carried out in collaboration with other scientists from the UK, Germany, Ireland, Austria and The Netherlands.
Dr Dietmar Zaiss, of the University of Edinburgh's School of Biological Sciences, who led the study, said: "We found an entirely new mechanism by which immune responses against parasites are regulated. These findings give us fresh insight into the functioning of local immune responses and should allow us to develop better vaccines against parasite infections."
This article has been republished from materials provided by The University of Edinburgh. Note: material may have been edited for length and content. For further information, please contact the cited source.
Kidney Cancer Driver Could Lead to New Treatment StrategyNews
Scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change can lead to an overabundance of blood vessels, which help feed nutrients to the tumors. Their latest finding shows a potential new cancer-driving pathway.READ MORE
Targeting Headaches and Tumors with Nano-SubmarinesNews
Scientists have developed a new method to enable miniature drug-filled nanocarriers to dock on to immune cells, which in turn attack tumors. In the future, this may lead to targeted treatment that can largely eliminate damage to healthy tissue.READ MORE
Working Together Helps Phage Overcome CRISPRNews
Surprising results show that phage join forces to overcome bacteria’s CRISPR -based immune defenses. Improved understanding of the interactions between phage and their bacterial hosts could help advance phage-based therapies and stimulate viral research.READ MORE